Possible influence of mammographic density on local and locoregional recurrence of breast cancer

Breast Cancer Research

Volumn 15, Issue 4, 2013, Pages

  Eriksson, Louise ^a   Czene, Kamila ^a   Rosenberg, Lena ^b   Humphreys, Keith ^a   Hall, Per ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; COMPUTER ASSISTED RADIOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; POPULATION BASED CASE CONTROL STUDY; POSTMENOPAUSE; RADIOLOGICAL PARAMETERS; SURGICAL TECHNIQUE; SWEDEN; BREAST NEOPLASMS; CANCER GRADING; CANCER STAGING; CASE CONTROL STUDY; LYMPH NODE METASTASIS; MAMMARY GLAND; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RADIOGRAPHY; REGISTER; TUMOR RECURRENCE;

AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAMMARY GLANDS, HUMAN; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; REGISTRIES; SWEDEN;

EID: 84880005531     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3450     Document Type: Article

References (39)

1. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006, 15:1159-1169. 10.1158/1055-9965.EPI-06-0034, 16775176.
2. Warren R, Lakhani SR. Can the stroma provide the clue to the cellular basis for mammographic density?. Breast Cancer Res 2003, 5:225-227. 10.1186/bcr642, 314441, 12927028.
3. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674. 10.1016/j.cell.2011.02.013, 21376230.
4. Antoni S, Sasco AJ, dos Santos Silva I, McCormack V. Is mammographic density differentially associated with breast cancer according to receptor status? A meta-analysis. Breast Cancer Res Treat 2013, 137:337-347. 10.1007/s10549-012-2362-4, 23239150.
5. Boyd NF, Martin LJ, Yaffe MJ, Minkin S. Mammographic density and breast cancer risk: current understanding and future prospects. Breast Cancer Res 2011, 13:223. 10.1186/bcr2942, 3326547, 22114898.
6. Eriksson L, Czene K, Rosenberg L, Humphreys K, Hall P. The influence of mammographic density on breast tumor characteristics. Breast Cancer Res Treat 2012, 134:859-866. 10.1007/s10549-012-2127-0, 22710708.
7. Heusinger K, Jud SM, Haberle L, Hack CC, Adamietz BR, Meier-Meitinger M, Lux MP, Wittenberg T, Wagner F, Loehberg CR, Uder M, Hartmann A, Schulz-Wendtland R, Beckmann MW, Fasching PA. Association of mammographic density with hormone receptors in invasive breast cancers: Results from a case-only study. Int J Cancer 2012, 131:2643-2649. 10.1002/ijc.27515, 22392346.
8. Pollan M, Ascunce N, Ederra M, Murillo A, Erdozain N, Ales-Martinez JE, Pastor-Barriuso R. Mammographic density and risk of breast cancer according to tumor characteristics and mode of detection: a Spanish population-based case-control study. Breast Cancer Res 2013, 15:R9. 10.1186/bcr3380, 3672793, 23360535.
9. Yaghjyan L, Colditz GA, Collins LC, Schnitt SJ, Rosner B, Vachon C, Tamimi RM. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst 2011, 103:1179-1189. 10.1093/jnci/djr225, 3149043, 21795664.
10. Gierach GL, Ichikawa L, Kerlikowske K, Brinton LA, Farhat GN, Vacek PM, Weaver DL, Schairer C, Taplin SH, Sherman ME. Relationship between mammographic density and breast cancer death in the breast cancer surveillance consortium. J Natl Cancer Inst 2012, 104:1218-1227. 10.1093/jnci/djs327, 3611814, 22911616.
11. Chiu SY, Duffy S, Yen AM, Tabar L, Smith RA, Chen HH. Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening. Cancer Epidemiol Biomarkers Prev 2010, 19:1219-1228. 10.1158/1055-9965.EPI-09-1028, 20406961.
12. Olsen AH, Bihrmann K, Jensen MB, Vejborg I, Lynge E. Breast density and outcome of mammography screening: a cohort study. Br J Cancer 2009, 100:1205-1208. 10.1038/sj.bjc.6604989, 2669986, 19293800.
13. Cil T, Fishell E, Hanna W, Sun P, Rawlinson E, Narod SA, McCready DR. Mammographic density and the risk of breast cancer recurrence after breast-conserving surgery. Cancer 2009, 115:5780-5787. 10.1002/cncr.24638, 19902459.
14. Magnusson C, Baron JA, Correia N, Bergstrom R, Adami HO, Persson I. Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer 1999, 81:339-344. 10.1002/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.0.CO;2-6, 10209946.
15. Guo YP, Martin LJ, Hanna W, Banerjee D, Miller N, Fishell E, Khokha R, Boyd NF. Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev 2001, 10:243-248.
16. Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, Hankinson SE. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 2000, 60:3744-3748.
17. Livshits G, Malkin I, Williams FM, Hart DJ, Hakim A, Spector TD. Longitudinal study of variation in body mass index in middle-aged UK females. Age (Dordr) 2012, 34:1285-1294.
18. Colacurci N, Fornaro F, De Franciscis P, Mele D, Palermo M, del Vecchio W. Effects of a short-term suspension of hormone replacement therapy on mammographic density. Fertil Steril 2001, 76:451-455. 10.1016/S0015-0282(01)01967-7, 11532463.
19. Nystrom L, Larsson LG, Rutqvist LE, Lindgren A, Lindqvist M, Ryden S, Andersson I, Bjurstam N, Fagerberg G, Frisell J, Tabár L. Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. A comparison between official statistics and validation by an endpoint committee. Acta Oncol 1995, 34:145-152. 10.3109/02841869509093948, 7718250.
20. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ. The quantitative analysis of mammographic densities. Phys Med Biol 1994, 39:1629-1638. 10.1088/0031-9155/39/10/008, 15551535.
21. Boyd NF, Byng JW, Jong RA, Fishell EK, Little LE, Miller AB, Lockwood GA, Tritchler DL, Yaffe MJ. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995, 87:670-675. 10.1093/jnci/87.9.670, 7752271.
22. Vachon CM, van Gils CH, Sellers TA, Ghosh K, Pruthi S, Brandt KR, Pankratz VS. Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res 2007, 9:217. 10.1186/bcr1829, 2246184, 18190724.
23. Chlebowski RT, Anderson GL. Changing concepts: menopausal hormone therapy and breast cancer. J Natl Cancer Inst 2012, 104:517-527. 10.1093/jnci/djs014, 3317878, 22427684.
24. Ewertz M, Jensen MB, Gunnarsdottir KA, Hojris I, Jakobsen EH, Nielsen D, Stenbygaard LE, Tange UB, Cold S. Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol 2011, 29:25-31. 10.1200/JCO.2010.29.7614, 21115856.
25. Narod SA. Hormone replacement therapy and the risk of breast cancer. Nat Rev Clin Oncol 2011, 8:669-676. 10.1038/nrclinonc.2011.110, 21808267.
26. Narod SA. Breast cancer in young women. Nat Rev Clin Oncol 2012, 9:460-470. 10.1038/nrclinonc.2012.102, 22733233.
27. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn HJ. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 2001, 19:3817-3827.
28. Joensuu H, Lehtimaki T, Holli K, Elomaa L, Turpeenniemi-Hujanen T, Kataja V, Anttila A, Lundin M, Isola J, Lundin J. Risk for distant recurrence of breast cancer detected by mammography screening or other methods. JAMA 2004, 292:1064-1073. 10.1001/jama.292.9.1064, 15339900.
29. Park CC, Rembert J, Chew K, Moore D, Kerlikowske K. High mammographic breast density is independent predictor of local but not distant recurrence after lumpectomy and radiotherapy for invasive breast cancer. Int J Radiat Oncol Biol Phys 2009, 73:75-79. 10.1016/j.ijrobp.2008.04.007, 18692323.
30. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y. Early Breast Cancer Trialists Collaborative Group (EBCTCG) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 366:2087-2106. Early Breast Cancer Trialists Collaborative Group (EBCTCG).
31. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 235:177-182. 10.1126/science.3798106, 3798106.
32. de Azambuja E, Cardoso F, de Castro G, Colozza M, Mano MS, Durbecq V, Sotiriou C, Larsimont D, Piccart-Gebhart MJ, Paesmans M. Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br J Cancer 2007, 96:1504-1513. 10.1038/sj.bjc.6603756, 2359936, 17453008.
33. Heusinger K, Jud SM, Haberle L, Hack CC, Fasching PA, Meier-Meitinger M, Lux MP, Hagenbeck C, Loehberg CR, Wittenberg T, Rauh C, Wagner F, Uder M, Hartmann A, Schulz-Wendtland R, Beckmann MW, Wachter DL. Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancer. Breast Cancer Res Treat 2012, 135:885-892. 10.1007/s10549-012-2221-3, 22936391.
34. Ma H, Luo J, Press MF, Wang Y, Bernstein L, Ursin G. Is there a difference in the association between percent mammographic density and subtypes of breast cancer? Luminal A and triple-negative breast cancer. Cancer Epidemiol Biomarkers Prev 2009, 18:479-485. 10.1158/1055-9965.EPI-08-0805, 19190139.
35. Kim MY, Oskarsson T, Acharyya S, Nguyen DX, Zhang XH, Norton L, Massague J. Tumor self-seeding by circulating cancer cells. Cell 2009, 139:1315-1326. 10.1016/j.cell.2009.11.025, 2810531, 20064377.
36. Comen E, Norton L, Massague J. Clinical implications of cancer self-seeding. Nat Rev Clin Oncol 2011, 8:369-377.
37. Alowami S, Troup S, Al-Haddad S, Kirkpatrick I, Watson PH. Mammographic density is related to stroma and stromal proteoglycan expression. Breast Cancer Res 2003, 5:R129-135. 10.1186/bcr622, 314426, 12927043.
38. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SF, Csiszar K, Giaccia A, Weninger W, Yamauchi M, Gasser DL, Weaver VM. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009, 139:891-906. 10.1016/j.cell.2009.10.027, 2788004, 19931152.
39. Li T, Sun L, Miller N, Nicklee T, Woo J, Hulse-Smith L, Tsao MS, Khokha R, Martin L, Boyd N. The association of measured breast tissue characteristics with mammographic density and other risk factors for breast cancer. Cancer Epidemiol Biomarkers Prev 2005, 14:343-349. 10.1158/1055-9965.EPI-04-0490, 15734956.